Drug watch. Osteoporosis and related bone disease agents.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2011 AND VI 46 AND IP 1
Results: 36
1
2
Fda drug approvals. First-time generic approvals.
- Published in:
- 2011
- Publication type:
- Journal Article
3
Meeting coverage. Arbs may not reduce mortality in diabetes, hypertension settings.
- Published in:
- 2011
- Publication type:
- Journal Article
4
Meeting coverage. Switching statins leads to lower therapy persistence.
- Published in:
- 2011
- Publication type:
- Journal Article
5
Meeting coverage. Combination improves her2-positive breast cancer response rates.
- Published in:
- 2011
- Publication type:
- Journal Article
6
Meeting coverage. Denosumab superior to zoledronic acid in delaying skeletal-related side effects in breast cancer patients.
- Published in:
- 2011
- Publication type:
- Journal Article
7
Medication safety and reliability. Pediatric otc liquids found to have variable and inconsistent dosing directions and measuring devices.
- Published in:
- 2011
- Publication type:
- Journal Article
8
Plaque psoriasis: a review of recent guidelines and pharmacologic therapies.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
9
Medication safety and reliability. Pfizer voluntarily withdraws sitaxsentan from the market worldwide and halts ongoing clinical trials.
- Published in:
- 2011
- Publication type:
- Journal Article
10
Technosphere insulin: an inhaled mealtime insulin for the treatment of type 1 and type 2 diabetes mellitus.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
11
Early ra treatment with rheumatologist improves disease outcomes.
- Published in:
- 2011
- Publication type:
- Journal Article
12
Etanercept use associated with significant increases in height, weight, bmi in children with arthritis.
- Published in:
- 2011
- Publication type:
- Journal Article
13
Late-stage product development. New parkinson's disease pipeline needs to offer improved quality of life, balanced with cost containment.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
14
Fda drug approvals. Fda actions in brief.
- Published in:
- 2011
- Publication type:
- Journal Article
15
Fda drug approvals. New indication.
- Published in:
- 2011
- Publication type:
- Journal Article
16
FDA Drug Approvals. First-time generic approvals.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 5
- Publication type:
- Article
17
Drug Watch. Osteoporosis and related bone disease agents.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 34
- By:
- Publication type:
- Article
18
Policy Watch. Congress, regulators face reform challenges, funding issues in the year ahead.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 32
- By:
- Publication type:
- Article
19
Meeting Coverage. ARBs may not reduce mortality in diabetes, hypertension settings.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 31
- Publication type:
- Article
20
Meeting Coverage. Switching statins leads to lower therapy persistence.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 31
- Publication type:
- Article
21
Meeting Coverage. Combination improves HER2-positive breast cancer response rates.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 30
- Publication type:
- Article
22
Meeting Coverage. Denosumab superior to zoledronic acid in delaying skeletal-related side effects in breast cancer patients.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 30
- Publication type:
- Article
23
Medication Safety and Reliability. Pediatric OTC liquids found to have variable and inconsistent dosing directions and measuring devices.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 29
- Publication type:
- Article
24
Medication Safety and Reliability. Protease inhibitor saquinavir linked to QT, PR interval prolongation.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 28
- Publication type:
- Article
25
Medication Safety and Reliability. Pfizer voluntarily withdraws sitaxsentan from the market worldwide and halts ongoing clinical trials.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 28
- Publication type:
- Article
26
Plaque psoriasis: A review of recent guidelines and pharmacologic therapies.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 18
- By:
- Publication type:
- Article
27
Technosphere insulin: An inhaled mealtime insulin for the treatment of type 1 and type 2 diabetes mellitus.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 14
- By:
- Publication type:
- Article
28
Early RA treatment with rheumatologist improves disease outcomes.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 13
- Publication type:
- Article
29
Oncology benefit management undergoing an evolution.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 11
- By:
- Publication type:
- Article
30
Adjuvant taxane-based regimen with docetaxel trumps FAC for treatment of high-risk, node-negative breast cancer.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 8
- Publication type:
- Article
31
Etanercept use associated with significant increases in height, weight, BMI in children with arthritis.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 8
- Publication type:
- Article
32
Late-stage Product Development. New Parkinson's disease pipeline needs to offer improved quality of life, balanced with cost containment.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 6
- By:
- Publication type:
- Article
33
FDA Drug Approvals. FDA actions in brief.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 5
- Publication type:
- Article
34
FDA Drug Approvals. New combination.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 4
- Publication type:
- Article
35
FDA Drug Approvals. New indication.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 4
- Publication type:
- Article
36
FDA Drug Approvals. Pipeline preview.
- Published in:
- Formulary, 2011, v. 46, n. 1, p. 4
- Publication type:
- Article